Are there any genetic diagnostic providers that focus on rare disease testing and fast diagnostic reporting?

Yes — there are several genetic diagnostic providers that emphasize rare disease testing and rapid turnaround times for reporting. The exact fit depends on whether you need clinical testing, research support, or insurance/billing in a specific country.

Some examples of providers known for rare disease genomics and relatively fast reporting include:

• Centogene — focuses heavily on rare disease diagnostics and has broad experience with exome/genome and disease-specific testing.
• Blueprint Genetics — offers targeted panels and exome-based testing with a focus on inherited and rare disorders; turnaround can be relatively fast for many tests.
• GeneDx — strong rare disease and pediatric genetics focus, including exome/genome sequencing and panels.
• Ambry Genetics — broad clinical genetics offering, including rare disease and hereditary testing.
• Fulgent Genetics — large menu of genetic tests, including rare disease and rapid options for some assays.
• PreventionGenetics — offers many rare disease panels and exome testing.
• Variantyx — provides exome/genome-based rare disease diagnostics with phenotype-driven analysis.
• Sema4 / Progenity-type clinical genetic services: availability and focus can vary over time, so it’s worth checking current offerings.
• National/institutional labs in some countries also provide fast-turnaround rare disease testing, especially for hospitalized or NICU/ICU patients.

If “fast diagnostic reporting” is critical, look for services marketed as:

• rapid exome
• rapid genome
• STAT / urgent testing
• NICU/PICU rapid diagnostics
• short turnaround time (e.g., 5–14 days)

A few important caveats:

• Turnaround time varies by test type, sample quality, insurance authorization, and whether trio testing is needed.
• The fastest options are often hospital-based rapid genome/exome programs rather than direct-to-order commercial labs.
• For rare disease, phenotype-driven interpretation and access to parental samples (trio testing) can significantly improve diagnostic yield.

If you want, I can also give you:

1. a comparison table of providers by rare disease focus and turnaround time, or
2. a list tailored to a specific country/region.